tolazamide and Vertigo
tolazamide has been researched along with Vertigo in 2 studies
Tolazamide: A sulphonylurea hypoglycemic agent with actions and uses similar to those of CHLORPROPAMIDE.
tolazamide : An N-sulfonylurea that is 1-tosylurea in which a hydrogen attached to the nitrogen at position 3 is replaced by an azepan-1-yl group. A hypoglycemic agent, it is used for the treatment of type 2 diabetes mellitus.
Vertigo: An illusion of movement, either of the external world revolving around the individual or of the individual revolving in space. Vertigo may be associated with disorders of the inner ear (EAR, INNER); VESTIBULAR NERVE; BRAINSTEM; or CEREBRAL CORTEX. Lesions in the TEMPORAL LOBE and PARIETAL LOBE may be associated with FOCAL SEIZURES that may feature vertigo as an ictal manifestation. (From Adams et al., Principles of Neurology, 6th ed, pp300-1)
Research
Studies (2)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Düntsch, G | 2 |
Other Studies
2 other studies available for tolazamide and Vertigo
Article | Year |
---|---|
[Results of oral therapy of diabetes mellitus with the new sulfonylurea tolazamide under ambulatory conditions].
Topics: Ambulatory Care; Blood Glucose; Cholesterol; Depression, Chemical; Diabetes Mellitus; Female; Humans | 1970 |
[Results of oral therapy of diabetes mellitus with the new sulfonylurea tolazamide under ambulatory conditions].
Topics: Ambulatory Care; Blood Glucose; Cholesterol; Depression, Chemical; Diabetes Mellitus; Female; Humans | 1970 |